PRESS RELEASE published on 10/31/2023 at 07:00, 1 year ago PolyPeptide signs scientific collaboration agreement
PRESS RELEASE published on 10/02/2023 at 07:00, 1 year 1 month ago PolyPeptide secures revolving credit facility
PRESS RELEASE published on 08/15/2023 at 07:00, 1 year 3 months ago Transformational progress taking shape, profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO
PRESS RELEASE published on 07/13/2023 at 07:00, 1 year 4 months ago PolyPeptide delivers revenue of around EUR 132 million for H1 – expects net loss for H1 and full year 2023
PRESS RELEASE published on 05/09/2023 at 20:40, 1 year 6 months ago PolyPeptide and Numaferm announce partnership to leverage their expertise for the more sustainable production of peptide-based APIs
PRESS RELEASE published on 04/12/2023 at 19:18, 1 year 7 months ago PolyPeptide announces results of the annual General Meeting 2023
PRESS RELEASE published on 04/03/2023 at 07:00, 1 year 7 months ago PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO
PRESS RELEASE published on 03/22/2023 at 07:00, 1 year 7 months ago PolyPeptide publishes invitation to the annual General Meeting 2023
Published on 11/21/2024 at 13:30, 15 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 15 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 45 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 45 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 45 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 9 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 30 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 47 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 25 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
